Our Awards

Certara is proud to have received several prestigious awards over recent years. These include:

2015

'R&D 100 Awards Finalist'

Certara’s Muse® InventTM was named a finalist in the “Software/Services” category of the R&D 100 Awards program.

‘NJBIZ Healthcare Heroes Finalist’

Certara was named a finalist in the “Innovation Hero” category of the NJBIZ Healthcare Heroes program.

‘Cool Vendor Designation by Gartner'

Certara’s ClinGenuity was named a “Cool Vendor” in Gartner, Inc.’s 2015 Life Sciences report. ClinGenuity was acquired by Synchrogenix, Certara’s regulatory writing company, in January 2015.

‘Society of Toxicology Outstanding Paper Award’

Authored by The Hamner Institutes for Health Sciences, the EPA, and Certara, this award-winning paper uses high-throughput toxicity testing to compare susceptibility between populations.


2014

‘American Association of Pharmaceutical Scientists Fellowship’

Amin Rostami, Pharm.D., Ph.D., FCP, the company’s vice president of research and development (R&D), was selected as a Fellow of the American Association of Pharmaceutical Scientists (AAPS) in recognition of his professional excellence and contributions to the fields of pharmacokinetics and pharmacology.


2010

‘The Queen’s Award for Enterprise’

This award has been made in the Innovation category and reflects Simcyp’s continuous development of modeling and simulation software for evaluating drugs in the safety of a computer. The Queen's Awards for Enterprise are the UK's most prestigious awards for business performance. The awards are made each year by Her Majesty the Queen, on the advice of the Prime Minister, assisted by an Advisory Committee of representatives of government, industry and commerce, and the trade unions.